GENEVA, March 9 -- JEIL PHARMACEUTICAL CO.,LTD (343 Sapyeong-daeroSeocho-guSeoul 06543), 제일약품주식회사 (서울특별시서초구사평대로 343) filed a patent application (PCT/IB2024/058201) for "NOVEL COMPOUND AS NLRP3 INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME" on Aug 23, 2024. With publication no. WO/2025/046419, the details related to the patent application was published on Mar 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): LEE, Changseok (7 Cheongganggachan...